|
DLC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.773940E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.06519999999389E-05 |
| Normal-vs-Stage2 |
1.545970E-02 |
| Normal-vs-Stage3 |
1.275740E-02 |
| Normal-vs-Stage4 |
2.638800E-01 |
| Stage1-vs-Stage2 |
8.146000E-01 |
| Stage1-vs-Stage3 |
1.868850E-01 |
| Stage1-vs-Stage4 |
1.282200E-03 |
| Stage2-vs-Stage3 |
5.240200E-01 |
| Stage2-vs-Stage4 |
8.117500E-02 |
| Stage3-vs-Stage4 |
8.423800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.413200E-04 |
| Normal-vs-AfricanAmerican |
3.719900E-02 |
| Normal-vs-Asian |
4.978400E-03 |
| Caucasian-vs-AfricanAmerican |
4.236400E-01 |
| Caucasian-vs-Asian |
8.593200E-01 |
| AfricanAmerican-vs-Asian |
4.036400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.163900E-02 |
| Normal-vs-Female |
4.3656000000003E-05 |
| Male-vs-Female |
2.035700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.45280000000081E-05 |
| Normal-vs-Age(41-60Yrs) |
1.622710E-03 |
| Normal-vs-Age(61-80Yrs) |
6.648200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.703220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.801410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.017800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.090600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.476800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.951800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.413600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.817500E-03 |
| Classical-VS-Follicular |
9.65719999967973E-07 |
| Classical-VS-Other |
5.046400E-02 |
| Classical-VS-Normal |
7.41330000053608E-07 |
| Tall-VS-Follicular |
3.437400E-01 |
| Tall-VS-Other |
1.266030E-01 |
| Tall-VS-Normal |
1.440570E-01 |
| Follicular-VS-Other |
3.857600E-01 |
| Follicular-VS-Normal |
5.626400E-01 |
| Other-VS-Normal |
5.086400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.058100E-03 |
| Normal-vs-N1 |
3.098000E-02 |
| N0-vs-N1 |
8.025800E-01 |
|
|
